tiprankstipranks
Trending News
More News >
AbbVie Hold Rating: Balancing Strong Immunology Growth with Challenges in Aesthetics, Neuroscience, and Oncology
PremiumRatingsAbbVie Hold Rating: Balancing Strong Immunology Growth with Challenges in Aesthetics, Neuroscience, and Oncology
6d ago
AbbVie reports European Commission grants marketing authorization to Rinvoq
Premium
The Fly
AbbVie reports European Commission grants marketing authorization to Rinvoq
7d ago
AbbVie assumed with a Neutral at Goldman Sachs
Premium
The Fly
AbbVie assumed with a Neutral at Goldman Sachs
7d ago
AbbVie sees FY25 adjusted EPS with expenses $11.99-$12.19, consensus $12.28
PremiumThe FlyAbbVie sees FY25 adjusted EPS with expenses $11.99-$12.19, consensus $12.28
11d ago
AbbVie’s Strategic Move into Obesity Treatment Boosts Buy Rating
Premium
Ratings
AbbVie’s Strategic Move into Obesity Treatment Boosts Buy Rating
13d ago
Pharmaceutical Industry Leaders Want to Delay Trump Tariffs
Premium
Market News
Pharmaceutical Industry Leaders Want to Delay Trump Tariffs
14d ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
22d ago
Nvidia, Exxon, AbbVie, Uber, Adobe: Insider Moves Unveiled
Premium
Weekend Updates
Nvidia, Exxon, AbbVie, Uber, Adobe: Insider Moves Unveiled
24d ago
AbbVie put volume heavy and directionally bearish
Premium
The Fly
AbbVie put volume heavy and directionally bearish
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100